DAL MONTE, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 10.042
NA - Nord America 3.840
AS - Asia 2.616
AF - Africa 184
SA - Sud America 170
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 16.859
Nazione #
IT - Italia 7.185
US - Stati Uniti d'America 3.788
SG - Singapore 947
GB - Regno Unito 843
CN - Cina 773
SE - Svezia 414
NL - Olanda 377
DE - Germania 326
VN - Vietnam 289
HK - Hong Kong 237
FR - Francia 192
IN - India 143
RU - Federazione Russa 142
BR - Brasile 124
IE - Irlanda 114
UA - Ucraina 109
KR - Corea 56
FI - Finlandia 47
EE - Estonia 46
CI - Costa d'Avorio 43
ZA - Sudafrica 42
BE - Belgio 41
PL - Polonia 39
SC - Seychelles 39
JP - Giappone 37
CH - Svizzera 35
CA - Canada 31
AT - Austria 26
JO - Giordania 26
TG - Togo 25
AR - Argentina 23
ID - Indonesia 23
BG - Bulgaria 21
MX - Messico 17
ES - Italia 15
GR - Grecia 13
CZ - Repubblica Ceca 11
PH - Filippine 11
RO - Romania 10
IR - Iran 9
TR - Turchia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
BD - Bangladesh 7
CM - Camerun 6
LT - Lituania 6
TW - Taiwan 6
AL - Albania 5
EC - Ecuador 5
EU - Europa 5
MY - Malesia 5
SM - San Marino 5
AO - Angola 4
CL - Cile 4
IQ - Iraq 4
LU - Lussemburgo 4
PE - Perù 4
PT - Portogallo 4
TH - Thailandia 4
VE - Venezuela 4
EG - Egitto 3
MA - Marocco 3
MT - Malta 3
NG - Nigeria 3
PY - Paraguay 3
UG - Uganda 3
AU - Australia 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
RE - Reunion 2
SA - Arabia Saudita 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KY - Cayman, isole 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
Totale 16.858
Città #
Southend 731
Singapore 591
Rome 587
Milan 568
Ashburn 477
Fairfield 331
Santa Clara 277
Chandler 252
Hong Kong 228
Bologna 204
Houston 199
Naples 173
Woodbridge 172
Wilmington 165
Seattle 145
Cambridge 132
Hefei 132
Turin 132
Ann Arbor 128
Beijing 128
Dublin 113
Princeton 111
Boardman 102
Padova 94
Florence 89
Palermo 89
Ho Chi Minh City 85
Verona 70
Dallas 69
Catania 67
Genoa 64
Bari 61
Hanoi 60
Jacksonville 58
New York 54
Seoul 52
Westminster 49
Nanjing 46
Bremen 44
Dong Ket 44
Abidjan 43
Los Angeles 43
Cagliari 40
Parma 39
Napoli 37
Berlin 35
Buffalo 33
Perugia 33
Helsinki 32
Brussels 31
Redondo Beach 31
Trieste 30
Jinan 28
Amman 26
Saint Petersburg 26
Tokyo 26
Torino 26
Changsha 25
Lomé 25
Modena 25
Redmond 24
Redwood City 24
Salerno 23
Brescia 22
Shenyang 22
Bolzano 20
Chicago 20
Hebei 20
Pisa 20
Reggio Emilia 20
Taranto 20
Monza 19
Pescara 19
San Diego 19
Bergamo 18
Bern 18
Frankfurt am Main 18
Nanchang 18
Sofia 18
Livorno 17
Messina 17
Sassari 17
São Paulo 17
Dearborn 16
Tianjin 16
Toronto 16
Zhengzhou 16
Bengaluru 15
Medford 15
Reggio Calabria 15
Shanghai 14
Trento 13
Vienna 13
Warsaw 13
Falkenstein 12
Jakarta 12
Munich 12
Venice 12
Citta 11
Des Moines 11
Totale 8.489
Nome #
Performance del test Quantiferon-TB Gold In-Tube nei pazienti con psoriasi e artrite psorisiaca nello screening e nel trattamento con farmaci anti-TNF-alfa 3.268
Effetto dell’età sulla risposta al mitogeno del test Quantiferon-TB Gold In-Tube nei pazienti pediatrici 2.313
Valutazione del sistema Cepheid Gene Xpert MTB/RIF in campioni respiratori e non respiratori per la diagnosi rapida di tubercolosi 739
Il test Quantiferon-TB Gold In-Tube nel bambino di eta’ inferiore a 5 anni: potenziale utilita’ clinica? 736
Performance del test Quantiferon-TB Gold In-Tube in campioni biologici diversi dal sangue provenienti da diversi distretti corporei 523
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 394
null 373
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 356
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 296
Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. 207
Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. 199
Evaluation of MALDI–TOF Mass Spectrometry in Diagnostic and Environmental Surveillance of Legionella Species: A Comparison With Culture and Mip-Gene Sequencing Technique 187
Andamento in base all’età della concordanza tra Quantiferon e test cutaneo alla tubercolina in bambini e adolescenti a contatto con adulti con tubercolosi polmonare 180
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 178
Development of Legionella pneumophila Serogroups Classification by FT-IRSpectroscopy with IR Biotyper System 162
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 162
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 162
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? 159
Does biological therapy affect interferon-γ release assay response? A long-term follow-up of patients with psoriasis using QuantiFERON-TB 156
Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity. 153
Latency-associated human cytomegalovirus glycoprotein N genotypes in monocytes from healthy blood donors. 151
Cytomegalovirus gN Genotypes Distribution among Congenitally Infected Newborns and Their Relationship with Symptoms at Birth and Sequelae. 150
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. 147
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. 147
Use of transrenal DNA for the diagnosis of extrapulmonary tuberculosis in children: a case of tubercular otitis media. 144
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 141
N-Thio-β-lactams targeting L,D-transpeptidase-2, with activity against drug-resistant strains of Mycobacterium tuberculosis 141
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 140
Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. 135
Simkania negevensis in Crohn’s Disease 131
Development of Legionella pneumophila serogroups classification by FT-IR spectroscopy with IR – Biotyper system 130
Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm. 129
Use of Fourier-Transform Infrared (FTIR) Spectroscopy with IR Biotyper® System for Legionella pneumophila serogroups identification 129
Performance of interferon-γ Release Assay for the Diagnosis of Active or Latent Tuberculosis in Children in the First 2 Years of Age 128
IGRA test for TB in COVID-19: role of corticosteroids 126
Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCR. 125
Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53. 122
Development of a multiplex PCR for the simultaneous amplification and genotyping of glycoprotein N among human cytomegalovirus strains. 121
Detection of Mycobacterium chimaera in medical device water samples by customised real time PCR using a InGenius platform 120
Epidemiology of human cytomegalovirus strains through comparison of methodological approaches to explore gN variants. 119
Utilita’ diagnostica del test Quantiferon-TB nei pazienti pediatrici in un’area a bassa incidenza di tubercolosi con alto tasso di immigrazione 119
First independent evaluation of QuantiFERON-TB Plus performance 119
Tubercolosi "extensively drug resistant" (XDR) in pazienti recentemente immigrati dal Paesi dell'Est Europeo. Aspetti microbiologici e terapeutici, ruolo dei farmaci di seconda scelta, e problematiche gestionali e di Sanità Pubblica 117
Indeterminate Quantiferon-TB Gold In-Tube results in children: association with pneumonia? 114
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 114
Tuberculosis in migrants from 106 countries to Italy, 2008-2014 110
HCMV Gn genotypes distribution among congenitally infected newborns monitored during one –year follow-up 110
Use of BD BACTEC™ MGIT™ for the detection of non-tuberculous mycobacteria in sanitary water samples 108
Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis 108
Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication. 107
Tuberculosis infection in young children: a screening based on skin and blood testing 106
Cytomegalovirus primary envelopment at large nuclear membrane infoldings: what's new? 106
Unexpectedly slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. A possible pathomorphism of pulmonary tuberculosis? 105
Sanitary Waters: Is It Worth Looking for Mycobacteria? 104
Cytomegalovirus infection via mother's milk: could distinct virus strains determine different disease patterns in preterm twins? 102
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 102
null 93
Quantiferon-TB Gold In-Tube Improves Tuberculosis Diagnosis in Children 90
Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016 87
A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. 85
Quantitative analysis of interferon-γ release assay response in children with latent and active tuberculosis 83
null 82
Investigating the Origin of Mycobacterium chimaera Contamination in Heater-Cooler Units: Integrated Analysis with Fourier Transform Infrared Spectroscopy and Whole-Genome Sequencing 80
Mycobacterium bovis isolates from humans: genetic profiles comparison with genotype database of animal tuberculosis strains isolated in Italy from 2000 to 2012 77
Retinoids and cancer: Antitumoral effects of ATRA, 9-cis RA and the new retinoid IIF on the HL-60 leukemic cell line 73
MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria 71
Multicenter evaluation of xpert MTB/RIF ultra tests reporting detection of 'Trace' of Mycobacterium tuberculosis DNA 70
TB mortality in low-incidence countries: can we reduce it further? 68
First isolation of Mycobacterium saskatchewanense from medical devices 63
Liver transplantation during anti-TB treatment 61
Identification of mitochondria in liver biopsies. A study by immunohistochemistry, immunogold and Western blot analysis 57
Analysis of intracellular and intraviral localization of the human cytomegalovirus UL53 protein 55
Comparison between virology and serology for the follow-up of cytomegalovirus infection in heart transplant recipients 50
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 50
Immunoelectron microscopy analysis of HCMV gpUL73 (gN) localization: Brief report 46
Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes 44
Adenine glycosylase activity in mammalian tissues: an equivalent of ribosome-inactivating proteins 41
Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure 39
Human cytomegalovirus glycoprotein N genotypes in AIDS patients 34
Complex Formation by Human Cytomegalovirus Glycoproteins M (gpUL100) and N (gpUL73) 33
The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73) 31
MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria 31
Prokaryotic expression of human cytomegalovirus pUS22 and its reactivity with human antibody 31
null 31
gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes 30
Five-year surveillance of human tuberculosis caused by Mycobacterium bovis in Bologna, Italy: an underestimated problem 28
Expression of human cytomegalovirus ppUL83 (pp65) in a stable cell line and its association with metaphase chromosomes 26
Totale 17.070
Categoria #
all - tutte 36.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021918 0 0 0 0 0 105 87 115 172 124 120 195
2021/20221.577 96 81 98 180 159 105 56 126 93 93 273 217
2022/20232.325 158 163 116 247 179 207 140 191 387 147 209 181
2023/20242.284 131 157 166 169 214 162 204 159 170 192 254 306
2024/20254.106 352 442 342 357 556 274 355 319 205 307 207 390
2025/20262.349 464 495 410 320 552 108 0 0 0 0 0 0
Totale 17.070